Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study by Garfinkel D, Zorin M, Wainstein J, Matas Z, Laudon M, Zisapel N

Get full text

Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: Outcomes from TECOS. by Engel, S, Suryawanshi, S, Stevens, S, Josse, R, Cornel, J, Jakuboniene, N, Riefflin, A, Tankova, T, Wainstein, J, Peterson, E, Holman, R, TECOS Study Group

Effect of sitagliptin on kidney function and respective cardiovascular outcomes in type 2 diabetes: Outcomes from TECOS. by Cornel, J, Bakris, G, Stevens, S, Alvarsson, M, Bax, W, Chuang, L, Engel, S, Lopes, R, McGuire, D, Riefflin, A, Rodbard, H, Sinay, I, Tankova, T, Wainstein, J, Peterson, E, Holman, R

Pancreatic safety of sitagliptin in the TECOS Study. by Buse, J, Bethel, M, Green, J, Stevens, S, Lokhnygina, Y, Aschner, P, Grado, C, Tankova, T, Wainstein, J, Josse, R, Lachin, J, Engel, S, Patel, K, Peterson, E, Holman, R, TECOS Study Group